Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap
BIOFACE PASS
Standard of Care Pathways Evaluation of Patients Treated for Facial Reconstruction After Surgery for Head and Neck Cancer, Using the Conventional Technique (Free Bone Flap): a Medico-economic Study
2 other identifiers
observational
200
1 country
9
Brief Summary
The purpose of this study is to describe the standard of care pathway of patients treated by free bone flap for facial mandibullar or maxillar reconstruction after surgery for head and neck cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Longer than P75 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2025
CompletedStudy Start
First participant enrolled
September 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
September 22, 2025
September 1, 2025
4.2 years
January 7, 2025
September 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Description of the standard of care pathway of patients treated by free bone flap for facial mandibullar or maxillar reconstruction after surgery for head and neck cancers
The primary outcome measure is a composite endpoint consisting of the description of care pathways based on care consumption (scheduled and unscheduled hospitalizations and consultations, medical procedures and medications). The study of pathways will take into account data from the National Health Data System (i.e. healthcare consumption). These data will then be aggregated and structured to form time sequences representing the care pathways (and classes of care pathways) of patients using the optimal matching method. These sequences will include several medical events such as consultations, treatments, hospitalizations for example. This will provide us with a simplified but detailed representation of care trajectories. The individual care sequences thus constructed will allow us to carry out sequence analyzes aimed at creating patient clusters.
12 months
Study Arms (1)
Patients with oral cavity cancer or maxillary and/or oropharynx cancer
Patients with oral cavity cancer or maxillary and/or oropharynx cancer eligible for treatment by surgery requiring a mandibulectomy or segmental maxillectomy and having a free bone flap for facial reconstruction.
Interventions
Quality of life questionnaires, questionnaires for assessing functional results, micro-costing questionnaire, informal support assessment questionnaires
Eligibility Criteria
Participation in the protocol will be offered to all patients meeting the eligibility criteria during the 3-year inclusion period. It is planned to include 200 operated patients, including 50 treated by maxillectomy and 150 treated by mandibulectomy. Nine French cancer centers and university hospitals will participate in the project: the University Hospitals of Toulouse, Amiens, Rouen, Lille, Montpellier, Nantes, the Gustave Roussy Institute, the Antoine Lacassagne Center (Nice) and the Hospices Civil de Lyon.
You may qualify if:
- Patient with oral cavity cancer or maxillary and/or oropharynx cancer
- Eligible for treatment by surgery requiring a mandibulectomy or segmental maxillectomy and having a free bone flap for facial reconstruction.
- Patient whose disease is classified Stage cT4a, N0 to N3, M0
- Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose)
- Age greater than or equal to 18 years
- Patient affiliated to a Social Security scheme in France
- Patient having given written informed consent
- Patient having had previous radiotherapy
- Patient with severe coagulation disorders
- Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
University hospital of Amiens- Picardie
Amiens, 80054, France
University hospital of Lille
Lille, 59037, France
Hospices Civils de Lyon
Lyon, 69004, France
University hospital of Montpellier
Montpellier, 34090, France
University hospital of Nantes
Nantes, 44093, France
Centre Antoine Lacassagne
Nice, 06189, France
University hospital of Rouen
Rouen, 76000, France
University hospital of Toulouse
Toulouse, 31059, France
Institut Gustave Roussy
Villejuif, 94805, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnès DUPRET-BORIES
University Hospital, Toulouse
Central Study Contacts
Camille Dumon
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2025
First Posted
January 13, 2025
Study Start
September 3, 2025
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
December 1, 2029
Last Updated
September 22, 2025
Record last verified: 2025-09